Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

Cited by (863)

Items 101–200 of 863

1. The Neuro-Immune Pathophysiology of Central and Peripheral Fatigue in Systemic Immune-Inflammatory and Neuro-Immune Diseases
   Gerwyn Morris, Michael Berk, Piotr Gałecki, Ken R. Walder, Michael H. J. Maes · 2015 · Molecular Neurobiology
2. Metabolic Dysfunction in Parkinson’s Disease: Bioenergetics, Redox Homeostasis and Central Carbon Metabolism
   Annadurai Anandhan, Maria S. Jacome, Shulei Lei, Pablo Hernández-Franco, Aglaia Pappa, Mihalis I. Panayiotidis, Robert Powers, Rodrigo Franco · 2017 · Brain Research Bulletin
3. Increased Immune Activation by Pathologic α‐Synuclein in Parkinson's Disease
   Grozdanov, Veselin, Bousset, Luc, Hoffmeister, Meike, Bliederhaeuser, Corinna, Meier, Christoph, Madiona, Karine, Pieri, Laura, Kiechle, Martin, McLean, Pamela J., Kassubek, Jan et al. · 2019 · Annals of Neurology
4. Extracellular Interactions of Alpha-Synuclein in Multiple System Atrophy
   Dario Valdinocci, Rowan A. W. Radford, Michael Goulding, Junna Hayashi, Roger S. Chung, Dean L. Pountney · 2018 · International Journal of Molecular Sciences
5. The cell biology of Parkinson’s disease
   Nikhil Panicker, Preston Ge, Valina Lynn Dawson, Ted M. Dawson · 2021 · The Journal of Cell Biology
6. NADPH oxidases in Parkinson’s disease: a systematic review
   Karim Bélarbi, Elodie Cuvelier, A. Destée, Bernard Gressier, Marie‐Christine Chartier‐Harlin · 2017 · Molecular Neurodegeneration
7. Immunotherapy targeting toll-like receptor 2 alleviates neurodegeneration in models of synucleinopathy by modulating α-synuclein transmission and neuroinflammation
   Kim, Changyoun, Spencer, Brian, Rockenstein, Edward, Yamakado, Hodaka, Mante, Michael, Adame, Anthony, Fields, Jerel Adam, Masliah, Deborah, Iba, Michiyo, Lee, He-Jin et al. · 2018 · Molecular Neurodegeneration
8. Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration
   García-Revilla, Juan, Boza-Serrano, Antonio, Espinosa-Oliva, Ana M., Soto, Manuel Sarmiento, Deierborg, Tomas, Ruiz, Rocío, de Pablos, Rocío M., Burguillos, Miguel Angel, Venero, Jose L. · 2022 · Cell Death & Disease
9. Pathological α-synuclein exacerbates the progression of Parkinson’s disease through microglial activation
   Zhang, Qiu-Shuang, Heng, Yang, Yuan, Yu-He, Chen, Nai-Hong · 2017 · Toxicology Letters
10. Toll-like receptor expression in the blood and brain of patients and a mouse model of Parkinson's disease
    Drouin-Ouellet, J., St-Amour, I., Saint-Pierre, M., Lamontagne-Proulx, J., Kriz, J., Barker, R. A., Cicchetti, F. · 2015 · International Journal of Neuropsychopharmacology
11. α-Synuclein, a chemoattractant, directs microglial migration via H 2 O 2 -dependent Lyn phosphorylation
    Shijun Wang, Chun‐Hsien Chu, Tessandra Stewart, Carmen Ginghină, Yifei Wang, Hui Nie, Mingri Guo, Belinda C. Wilson, Jau‐Shyong Hong, Jing Zhang · 2015 · Proceedings of the National Academy of Sciences
12. Signal transduction and epigenetic mechanisms in the control of microglia activation during neuroinflammation
    Bozena Kaminska, Mariana Mota, Marina Pizzi · 2015 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
13. Manganese exposure induces neuroinflammation by impairing mitochondrial dynamics in astrocytes
    Souvarish Sarkar, Emir Malovic, Dilshan S. Harischandra, Hilary Afeseh Ngwa, Anamitra Ghosh, Colleen Hogan, Dharmin Rokad, Gary D. Zenitsky, Huajun Jin, Vellareddy Anantharam et al. · 2017 · NeuroToxicology
14. Beyond the gut: decoding the gut–immune–brain axis in health and disease
    Park, John Chulhoon, Chang, Leechung, Kwon, Ho-Keun, Im, Sin-Hyeog · 2025 · Cellular & Molecular Immunology
15. α‐synuclein suppresses microglial autophagy and promotes neurodegeneration in a mouse model of Parkinson’s disease
    Tu, Hai‐Yue, Yuan, Bao‐Shi, Hou, Xiao‐Ou, Zhang, Xiao‐Jun, Pei, Chong‐Shuang, Ma, Ya‐Ting, Yang, Ya‐Ping, Fan, Yi, Qin, Zheng‐Hong, Liu, Chun‐Feng et al. · 2021 · Aging Cell
16. Extracellular α-synuclein levels are regulated by neuronal activity
    Yamada, Kaoru, Iwatsubo, Takeshi · 2018 · Molecular Neurodegeneration
17. Prion-like Mechanisms in the Pathogenesis of Tauopathies and Synucleinopathies
    Michel Goedert, Ben Falcon, Florence Clavaguera, Markus Tolnay · 2014 · Current Neurology and Neuroscience Reports
18. Toll-like receptors and their therapeutic potential in Parkinson’s disease and α-synucleinopathies
    Kouli, Antonina, Horne, C.B., Williams-Gray, C.H. · 2019 · Brain Behavior and Immunity
19. The immune system in Parkinson's disease: what we know so far
    Cintia Roodveldt, Liliana Inácio Bernardino, Özgür Öztop Çakmak, Milorad Dragić, Kari Espolin Fladmark, Sibel Ertan, Büşra Aktaş, Carlos Pita, Lucia Ciglar, Gaëtan Garraux et al. · 2024 · Brain
20. Exosomes in Parkinson disease
    Jennifer R. Pinnell, Mei Cui, Kim Tieu · 2020 · Journal of Neurochemistry
21. Pharmacological Targeting of Microglial Activation: New Therapeutic Approach
    Caiyun Liu, Xu Wang, Chang Liu, Hongliang Zhang · 2019 · Frontiers in Cellular Neuroscience
22. Brain Injection of α-Synuclein Induces Multiple Proteinopathies, Gliosis, and a Neuronal Injury Marker
    Sacino, Amanda N., Brooks, Mieu, McKinney, Alex B., Thomas, Michael A., Shaw, Gerry, Golde, Todd E., Giasson, Benoit I. · 2014 · The Journal of Neuroscience
23. TLR2 & Co: a critical analysis of the complex interactions between TLR2 and coreceptors
    Jeroen van Bergenhenegouwen, Theo S. Plantinga, Leo A. B. Joosten, Mihai Gheorghe Netea, Gert Folkerts, Aletta D. Kraneveld, Johan Garssen, Arjan P. Vos · 2013 · Journal of Leukocyte Biology
24. NK cells clear α-synuclein and the depletion of NK cells exacerbates synuclein pathology in a mouse model of α-synucleinopathy
    Rachael H. Earls, Kelly B. Menees, Jaegwon Chung, Claire‐Anne Gutekunst, Hyun Joon Lee, Manuel G. Hazim, Balázs Rada, Levi Benjamin Wood, Jae‐Kyung Lee · 2020 · Proceedings of the National Academy of Sciences
25. Aging causes morphological alterations in astrocytes and microglia in human substantia nigra pars compacta
    Jyothi, H.J., Vidyadhara, D.J., Mahadevan, Anita, Philip, Mariamma, Parmar, Suresh Kumar, Manohari, S. Gowri, Shankar, S.K., Raju, Trichur R., Alladi, Phalguni Anand · 2015 · Neurobiology of Aging
26. Intrastriatal injection of preformed alpha-synuclein fibrils alters central and peripheral immune cell profiles in non-transgenic mice
    Earls, Rachael H., Menees, Kelly B., Chung, Jaegwon, Barber, James, Gutekunst, Claire-Anne, Hazim, Manuel G., Lee, Jae-Kyung · 2019 · Journal of Neuroinflammation
27. Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril
    Kim, Changyoun, Lv, Guohua, Lee, Jun Sung, Jung, Byung Chul, Masuda-Suzukake, Masami, Hong, Chul-Suk, Valera, Elvira, Lee, He-Jin, Paik, Seung R., Hasegawa, Masato et al. · 2016 · Scientific Reports
28. Antagonizing Neuronal Toll-like Receptor 2 Prevents Synucleinopathy by Activating Autophagy
    Kim, Changyoun, Rockenstein, Edward, Spencer, Brian, Kim, Hyung-Koo, Adame, Anthony, Trejo, Margarita, Stafa, Klodjan, Lee, He-Jin, Lee, Seung-Jae, Masliah, Eliezer · 2015 · Cell Reports
29. The complex relationships between microglia, alpha-synuclein, and LRRK2 in Parkinson's disease
    Schapansky, J., Nardozzi, J.D., LaVoie, M.J. · 2015 · Neuroscience
30. Soluble α-synuclein–antibody complexes activate the NLRP3 inflammasome in hiPSC-derived microglia
    Dorit Trudler, Kristopher L. Nazor, Yvonne S. Eisele, Titas Grabauskas, Nima Dolatabadi, James Parker, Abdullah Sultan, Zhenyu Zhong, Marshall S. Goodwin, Yona Levites et al. · 2021 · Proceedings of the National Academy of Sciences
31. Neuropathology of α‐synuclein propagation and braak hypothesis
    Heather McCann, Heidi Cartwright, Glenda Margaret Halliday · 2015 · Movement Disorders
32. Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells
    Isabella Russo, Giulia Berti, Nicoletta Plotegher, Greta Bernardo, Roberta Filograna, Luigi Bubacco, Elisa Greggio · 2015 · Journal of Neuroinflammation
33. Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases
    Minee L. Choi, Sonia Gandhi · 2018 · FEBS Journal
34. Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production
    Tapias, Victor, Hu, Xiaoping, Luk, Kelvin C., Sanders, Laurie H., Lee, Virginia M., Greenamyre, J. Timothy · 2017 · Cellular and Molecular Life Sciences
35. ɑ-Synuclein strains and seeding in Parkinson’s disease, incidental Lewy body disease, dementia with Lewy bodies and multiple system atrophy: similarities and differences
    Wouter Peelaerts, Luc Bousset, Veerle Baekelandt, Ronald Melki · 2018 · Cell and Tissue Research
36. The Wnt/Ca2+ pathway is involved in interneuronal communication mediated by tunneling nanotubes
    Jessica Vargas, Frida Loría, Yuan-Ju Wu, Gonzalo Córdova, Takashi Nonaka, Sébastien Bellow, Sylvie Syan, Masato Hasegawa, Geeske M. van Woerden, Capucine Trollet et al. · 2019 · The EMBO Journal
37. Innate immune alterations are elicited in microglial cells before plaque deposition in the Alzheimer’s disease mouse model 5xFAD
    Antonio Boza‐Serrano, Yiyi Yang, Agnes Paulus, Tomas Deierborg · 2018 · Scientific Reports
38. P2X7 receptor is critical in α-synuclein–mediated microglial NADPH oxidase activation
    Jiang, Tianfang, Hoekstra, Jake, Heng, Xin, Kang, Wenyan, Ding, Jianqing, Liu, Jun, Chen, Shengdi, Zhang, Jing · 2015 · Neurobiology of Aging
39. The role of glucocerebrosidase in Parkinson disease pathogenesis
    Matthew E. Gegg, Anthony H.V. Schapira · 2018 · FEBS Journal
40. Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2
    Xia, Yun, Zhang, Guoxin, Kou, Liang, Yin, Sijia, Han, Chao, Hu, Junjie, Wan, Fang, Sun, Yadi, Wu, Jiawei, Li, Yunna et al. · 2021 · Brain
41. Microglial NLRP3 Inflammasome Activation Upon TLR2 and TLR5 Ligation by Distinct α-Synuclein Assemblies
    Scheiblich, Hannah, Bousset, Luc, Schwartz, Stephanie, Griep, Angelika, Latz, Eicke, Melki, Ronald, Heneka, Michael T · 2021 · The Journal of Immunology
42. Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies
    Roberta Cascella, Alessandra Bigi, Nunilo Cremades, Cristina Cecchi · 2022 · Cellular and Molecular Life Sciences
43. Imaging α-synuclein pathologies in animal models and patients with Parkinson’s and related diseases
    Hironobu Endo, Maiko Ono, Yuhei Takado, Kiwamu Matsuoka, Manami Takahashi, Kenji Tagai, Yuko Kataoka, Kosei Hirata, Keisuke Takahata, Chie Seki et al. · 2024 · Neuron
44. RETRACTED ARTICLE: Neuroinflammation is associated with infiltration of T cells in Lewy body disease and α-synuclein transgenic models
    Iba, Michiyo, Kim, Changyoun, Sallin, Michelle, Kwon, Somin, Verma, Anjali, Overk, Cassia, Rissman, Robert A., Sen, Ranjan, Sen, Jyoti Misra, Masliah, Eliezer · 2020 · Journal of Neuroinflammation · Retracted
45. Anle138b modulates α‐synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy
    Antonio Heras‐Garvin, Daniel Weckbecker, Sergey Ryazanov, Andrei Leonov, Christian Griesinger, Armin Giese, Gregor Karl Wenning, Nadia Stefanova · 2018 · Movement Disorders
46. Amyloidogenic α-synuclein seeds do not invariably induce rapid, widespread pathology in mice
    Amanda N. Sacino, Mieu Brooks, Michael A. Thomas, Alex B. McKinney, Nicholas H. McGarvey, Nicola J. Rutherford, Carolina Ceballos‐Diaz, Janice Robertson, Todd Eliot Golde, Benoit I. Giasson · 2014 · Acta Neuropathologica
47. Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson’s disease
    Souvarish Sarkar, Hai Minh Nguyen, Emir Malovic, Jie Denny Luo, Monica Renee Langley, Bharathi N. Palanisamy, Neeraj Singh, Sireesha Manne, Matthew P Neal, Michelle Gabrielle et al. · 2020 · Journal of Clinical Investigation
48. Mechanistic basis for receptor-mediated pathological α-synuclein fibril cell-to-cell transmission in Parkinson's disease
    Shengnan Zhang, Yuqing Liu, Chunyu Jia, Yeh‐Jun Lim, Guoqin Feng, Enquan Xu, Houfang Long, Yasuyoshi Kimura, Youqi Tao, Chunyu Zhao et al. · 2021 · Proceedings of the National Academy of Sciences
49. Inhibiting TLR2 activation attenuates amyloid accumulation and glial activation in a mouse model of Alzheimer’s disease
    McDonald, Claire L., Hennessy, Edel, Rubio-Araiz, Ana, Keogh, Brian, McCormack, William, McGuirk, Peter, Reilly, Mary, Lynch, Marina A. · 2016 · Brain, Behavior, and Immunity
50. New Perspectives on Roles of Alpha-Synuclein in Parkinson’s Disease
    Guoxin Zhang, Yun Fei Xia, Fang Jung Wan, Kai Ma, Xingfang Guo, Liang Kou, Sijia Yin, Chao Han, Ling Liu, Jinsha Huang et al. · 2018 · Frontiers in Aging Neuroscience
51. Innate and adaptive immune responses in Parkinson's disease
    Aubrey M Schonhoff, Gregory P. Williams, Zachary D. Wallen, David G. Standaert, Ashley S. Harms · 2019 · Progress in brain research
52. Differential α-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity
    Esteban Luna, Samantha C. Decker, Dawn M. Riddle, Anna Caputo, Bin Zhang, Tracy A. Cole, Carrie Caswell, Sharon Xiangwen Xie, Virginia M.‐Y. Lee, Kelvin C. Luk · 2018 · Acta Neuropathologica
53. Do Microglial Sex Differences Contribute to Sex Differences in Neurodegenerative Diseases?
    Lay Kodama, Li Gan · 2019 · Trends in Molecular Medicine
54. Protective Microglia and Their Regulation in Parkinson’s Disease
    Weidong Le, Junjiao Wu, Yu Tang · 2016 · Frontiers in Molecular Neuroscience
55. The Interplay between Alpha-Synuclein Clearance and Spreading
    Tomás Lopes da Fonseca, Anna Villar‐Piqué, Tiago F. Outeiro · 2015 · Biomolecules
56. Brain region-specific gene expression profiles in freshly isolated rat microglia
    Karlijn J. Doorn, John J. P. Brevé, Benjamin Drukarch, H. W. G. M. Boddeke, Inge Huitinga, Paul John Lucassen, Anne‐Marie van Dam · 2015 · Frontiers in Cellular Neuroscience
57. Alpha Synuclein: Neurodegeneration and Inflammation
    Gianluigi Forloni · 2023 · International Journal of Molecular Sciences
58. Potential Modes of Intercellular α-Synuclein Transmission
    Dario Valdinocci, Rowan A. W. Radford, Sue Maye Siow, Roger S. Chung, Dean L. Pountney · 2017 · International Journal of Molecular Sciences
59. Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson’s disease
    Qian-Kun Lv, Kang‐Xin Tao, Xiao-Bo Wang, Xiao‐Yu Yao, Meng‐Zhu Pang, Junyi Liu, Fen Wang, Chun‐Feng Liu · 2023 · Inflammation Research
60. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease
    Jialong Chen, Kanmin Mao, Honglin Yu, Yue Wen, Hua She, He Zhang, Linhua Liu, Mingque Li, Wenjun Li, Fei Zou · 2021 · Journal of Neuroinflammation
61. TLR2 and TLR4 in Parkinson’s disease pathogenesis: The environment takes a toll on the gut
    Gorecki, Anastazja M., Anyaegbu, Chidozie C., Anderton, Ryan S. · 2021 · Translational Neurodegeneration
62. Alpha-synuclein activates BV2 microglia dependent on its aggregation state
    Alana Hoffmann, Benjamin Ettle, Ariane Bruno, Anna O. Kulinich, Anna-Carin Hoffmann, Julia von Wittgenstein, Jürgen Winkler, Wei Xiang, Johannes C. M. Schlachetzki · 2016 · Biochemical and Biophysical Research Communications
63. The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
    Doty, Kevin R., Guillot-Sestier, Marie-Victoire, Town, Terrence · 2015 · Brain Research
64. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease
    Richard Gordon, Neeraj Singh, Vivek Lawana, Anamitra Ghosh, Dilshan S. Harischandra, Huajun Jin, Colleen Hogan, Souvarish Sarkar, Dharmin Rokad, Nikhil Panicker et al. · 2016 · Neurobiology of Disease
65. Peripheral innate immune and bacterial signals relate to clinical heterogeneity in Parkinson’s disease
    Ruwani Wijeyekoon, Deborah Kronenberg‐Versteeg, Kirsten M. Scott, Shaista Hayat, Wei‐Li Kuan, Jonathan Evans, David P. Breen, Gemma A. Cummins, Joanne Jones, Menna Ruth Clatworthy et al. · 2020 · Brain Behavior and Immunity
66. Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
    Sindhu A. Menon, Sabrina E.M. Armstrong, Amir Mohammad Hamzeh, Naomi P. Visanji, S. Pablo Sardi, Anurag Tandon · 2022 · Frontiers in Neurology
67. α-Synuclein pathology as a target in neurodegenerative diseases
    Hye-Jin Park, Tae‐In Kam, Valina Lynn Dawson, Ted M. Dawson · 2024 · Nature Reviews Neurology
68. Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral α-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys
    M Chen, Tianyu Wang, Feng Yue, X. Li, Peichang Wang, Y. Li, Piu Chan, Shun Yu · 2014 · Neuroscience
69. Sorting out release, uptake and processing of alpha‐synuclein during prion‐like spread of pathology
    Trevor Tyson, Jennifer A. Steiner, Patrik Brundin · 2015 · Journal of Neurochemistry
70. DJ ‐1 deficiency impairs autophagy and reduces alpha‐synuclein phagocytosis by microglia
    Yuval Nash, Eran Schmukler, Dorit Trudler, Ronit Pinkas‐Kramarski, Dan Frenkel · 2017 · Journal of Neurochemistry
71. Pathogenic Impact of α-Synuclein Phosphorylation and Its Kinases in α-Synucleinopathies
    Kawahata, Ichiro, Finkelstein, David I., Fukunaga, Kohji · 2022 · International Journal of Molecular Sciences
72. Inflammatory response in Parkinson’s disease (Review)
    Junqiang Yan, Qizhi Fu, Li-Niu Cheng, MINGMING ZHAI, Wenjuan Wu, Lina Huang, Ganqin Du · 2014 · Molecular Medicine Reports
73. The A1 astrocyte paradigm: New avenues for pharmacological intervention in neurodegeneration
    Jared T. Hinkle, Valina Lynn Dawson, Ted M. Dawson · 2019 · Movement Disorders
74. Filamentous recombinant human Tau activates primary astrocytes via an integrin receptor complex
    Wang, Peng, Ye, Yihong · 2021 · Nature Communications
75. NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
    Qiu-Qin Han, W. Le · 2023 · Neuroscience Bulletin
76. Akkermansia muciniphila in neuropsychiatric disorders: friend or foe?
    Wenhui Lei, Yiwen Cheng, Jie Gao, Xia Liu, Li Shao, Qingming Kong, Nengneng Zheng, Zongxin Ling, Weiming Hu · 2023 · Frontiers in Cellular and Infection Microbiology
77. Correction to: Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson’s disease pathogenesis
    Craig D. Hughes, Minee L. Choi, Mina Ryten, Lee Hopkins, Anna Drews, Juan Antonio Botía, Maria Iljina, Margarida Rodrigues, Sarah A. Gagliano Taliun, Sonia Gandhi et al. · 2018 · Acta Neuropathologica
78. Integrin CD11b mediates α-synuclein-induced activation of NADPH oxidase through a Rho-dependent pathway
    Hou, Liyan, Bao, Xiuqi, Zang, Caixia, Yang, Hanyu, Sun, Fuqiang, Che, Yuning, Wu, Xuefei, Li, Shao, Zhang, Dan, Wang, Qingshan · 2018 · Redox Biology
79. Immunotherapy for Parkinson’s disease
    Aaron D. Schwab, Mackenzie J. Thurston, Jatin Machhi, Katherine E. Olson, Krista L. Namminga, Howard Eliot Gendelman, Rodney Lee Mosley · 2020 · Neurobiology of Disease
80. Neuroinflammation in Lewy body dementia
    Ajenthan Surendranathan, James Benedict Rowe, John Tiernan O'Brien · 2015 · Parkinsonism & Related Disorders
81. Neuroprotective effects of endurance exercise against neuroinflammation in MPTP-induced Parkinson's disease mice
    Yongchul Jang, Jung‐Hoon Koo, Insu Kwon, Eun‐Bum Kang, Hyun-Seob Um, Hideaki Soya, Youngil Lee, Joon‐Yong Cho · 2016 · Brain Research
82. LRRK2 Kinase Activity Induces Mitochondrial Fission in Microglia via Drp1 and Modulates Neuroinflammation
    Dong Hwan Ho, A Reum Je, Hae-Jin Lee, Ilhong Son, Hee‐Seok Kweon, Hyunggun Kim, Wongi Seol · 2018 · Experimental Neurobiology
83. Baicalein attenuates α-synuclein aggregation, inflammasome activation and autophagy in the MPP+-treated nigrostriatal dopaminergic system in vivo
    Kai-Chih Hung, Hui-Ju Huang, Yi-Ting Wang, Anya Maan-Yuh Lin · 2016 · Journal of Ethnopharmacology
84. TLR9 activation via microglial glucocorticoid receptors contributes to degeneration of midbrain dopamine neurons
    Maatouk, Layal, Compagnion, Anne-Claire, Sauvage, Maria-Angeles Carrillo-de, Bemelmans, Alexis-Pierre, Leclere-Turbant, Sabrina, Cirotteau, Vincent, Tohme, Mira, Beke, Allen, Trichet, Michaël, Bazin, Virginie et al. · 2018 · Nature Communications
85. Mitochondrial dysfunction in astrocytes: A role in Parkinson’s disease?
    Bantle, Collin M., Hirst, Warren D., Weihofen, Andreas, Shlevkov, Evgeny · 2021 · Frontiers in Cell and Developmental Biology
86. The role of Galectin-3 in α-synuclein-induced microglial activation
    Antonio Boza‐Serrano, Juan F. Reyes, Nolwen L. Rey, Hakon Leffler, Luc Bousset, Ulf J. Nilsson, Patrik Brundin, Jose Luis Venero, Miguel Ángel Burguillos, Tomas Deierborg · 2014 · Acta Neuropathologica Communications
87. Association of a common genetic variant with Parkinson’s disease is mediated by microglia
    Langston, Rebekah G., Beilina, Alexandra, Reed, Xylena, Kaganovich, Alice, Singleton, Andrew B., Blauwendraat, Cornelis, Gibbs, J. Raphael, Cookson, Mark R. · 2022 · Science Translational Medicine
88. Prion-like propagation of pathology in Parkinson disease
    Laura A. Volpicelli‐Daley, Patrik Brundin · 2018 · Handbook of clinical neurology
89. Prions and Protein Assemblies that Convey Biological Information in Health and Disease
    David W. Sanders, Sarah K. Kaufman, Brandon B. Holmes, Marc I. Diamond · 2016 · Neuron
90. Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets
    Somin Kwon, Michiyo Iba, Changyoun Kim, Eliezer Masliah · 2020 · Neurotherapeutics
91. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra
    Yang Heng, Qiu-Shuang Zhang, Zheng Mu, Jin‐Feng Hu, Yu‐He Yuan, Nai‐Hong Chen · 2015 · Toxicology Letters
92. Non-cell-autonomous Neurotoxicity of α-synuclein Through Microglial Toll-like Receptor 2
    Kim, Changyoun, Lee, He-Jin, Masliah, Eliezer, Lee, Seung-Jae · 2016 · Experimental Neurobiology
93. Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology
    Carolina Pellegrini, Vanessa D’Antongiovanni, Fabiana Miraglia, Lucia Rota, Laura Benvenuti, Clelia Di Salvo, Giovanna Testa, Simona Capsoni, Gianfranca Carta, Luca Antonioli et al. · 2022 · npj Parkinson s Disease
94. FcγRIIB mediates the inhibitory effect of aggregated α-synuclein on microglial phagocytosis
    Yu Ree Choi, Seo‐Jun Kang, Jin-Mo Kim, Seung‐Jae Lee, Ilo Jou, Eun-hye Joe, Sang Myun Park · 2015 · Neurobiology of Disease
95. RETRACTED ARTICLE: Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy
    Brian J. Spencer, Elvira Valera, Edward M. Rockenstein, Cassia Overk, Michael Mante, Anthony Adame, Wagner M. Zago, Peter A. Seubert, Robin Barbour, Dale Schenk et al. · 2017 · Acta Neuropathologica Communications · Retracted
96. Innate Immune Signaling and Alcohol Use Disorders
    Leon G. Coleman, Fulton T. Crews · 2018 · Handbook of experimental pharmacology
97. The role of natural killer cells in Parkinson’s disease
    Rachael H. Earls, Jae‐Kyung Lee · 2020 · Experimental & Molecular Medicine
98. Neuroinflammatory Responses and Parkinson’ Disease: Pathogenic Mechanisms and Therapeutic Targets
    Liuna Yang, Kanmin Mao, Honglin Yu, Jialong Chen · 2020 · Journal of Neuroimmune Pharmacology
99. Peripheral inflammation exacerbates α‐synuclein toxicity and neuropathology in Parkinson's models
    Pietro La Vitola, Claudia Balducci, Michela Baroni, Luisa Artioli, Giulia Santamaria, M. Castiglioni, Milica Cerovic, Laura Colombo, Laura Caldinelli, Loredano Pollegioni et al. · 2020 · Neuropathology and Applied Neurobiology
100. Tau fibrils induce glial inflammation and neuropathology via TLR2 in Alzheimer’s disease–related mouse models
     Dutta, Debashis, Jana, Malabendu, Paidi, Ramesh Kumar, Majumder, Moumita, Raha, Sumita, Dasarathy, Sridevi, Pahan, Kalipada · 2023 · Journal of Clinical Investigation